NCT00383370View on ClinicalTrials.gov

Safety and Tolerability of Intravitreal VEGF Trap Formulations in Subjects With Neovacular AMD

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

July 31, 2008

Conditions
Neovascular Age Related Macular Degeneration
Interventions
DRUG

VEGF Trap

VEGF Trap formulation 1, ITV-1

BIOLOGICAL

VEGF Trap

VEGF Trap formulation 2 at higher concentration in Open label cohort

Trial Locations (6)

21740

Hagerstown

29169

Columbia

33907

Fort Myers

67214

Wichita

78503

McAllen

78705

Austin

All Listed Sponsors
lead

Regeneron Pharmaceuticals

INDUSTRY

NCT00383370 - Safety and Tolerability of Intravitreal VEGF Trap Formulations in Subjects With Neovacular AMD | Biotech Hunter | Biotech Hunter